PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
06-Dec-2023 Americord Elevates Standards With Strategic Lab Relocation to Somerset, New Jersey AccessWire
06-Dec-2023 Connect America Appoints New Chief Medical Officer AccessWire
06-Dec-2023 Dragos Launches Community Defense Program to Help Secure Industrial Infrastructure for Small Utilities Businesswire
06-Dec-2023 Study Data on Quality of Life for Breast Cancer Patients and Survivors, Supported by Napo Pharmaceuticals (a Jaguar Health Family Company), Published on San Antonio Breast Cancer Symposium (SABCS) Website AccessWire
06-Dec-2023 Biosimilars Market Analysis and Forecast 2031: Opportunities in a Vital Pharmaceuticals Sector The Wire Times
06-Dec-2023 Laxxon Medical to Attend 42nd Annual J.P. Morgan Healthcare Conference in San Francisco AccessWire
06-Dec-2023 Clear Vision Center Office-Based Surgery Facility Receives QUAD A Certification AccessWire
06-Dec-2023 RNA Based Therapeutic Market growing significantly at 8.1% CAGR with $330.9 million by 2031 The Wire Times
06-Dec-2023 Kaneka Acquires Japan Medical Device Technology Businesswire
06-Dec-2023 Camena Bioscience Appoints Dr Nicola Thompson as Chair of the Board Businesswire
06-Dec-2023 New Glyphosate and Forever Chemicals Binding Strains Available for Commercialization AccessWire
06-Dec-2023 Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners AccessWire
06-Dec-2023 Genetic Testing Market Size to Cross USD 40.9 Billion by 2032, to Achieves CAGR of 10.2% from 2023 to 2032 The Wire Times
06-Dec-2023 Thermo Fisher Scientific Establishes 2030 Renewable Electricity Goal and Solar Power Purchase Agreement with ib vogt Businesswire
06-Dec-2023 Ribbon Biolabs Appoints Jodi Barrientos Chief Executive Officer; Founder Harold De Vladar Named an Advisor and Board Member Businesswire
06-Dec-2023 Dysphagia Supplement Market to Generate USD 2.3 Billion by 2032, Expeditious Annual Growth Predicted The Wire Times
06-Dec-2023 New Post Hoc Phase 3 Data Analysis Shows AJOVY® (fremanezumab) Reduced Migraine Attacks in Adults with Migraine and Co-morbid Obesity Businesswire
06-Dec-2023 TheraVet Reports Further Achievements on Its Osteosarcoma Program Businesswire
06-Dec-2023 Global Disposable Spinal Instruments Industry is poised to reach US$ 96.5 Million by 2028, owing to the escalating demand for minimally invasive surgical methods, as identified by FMI MARKITWIRED
06-Dec-2023 Mucus Clearance Devices Industry Poised to Surpass a Valuation of US$ 847.0 Million by 2028-FMI Report MARKITWIRED